Consecutive cycles in in vitro fertilization-embryo transfer

Gynecological Endocrinology

Volumn 20, Issue 3, 2005, Pages 132-136

  Doldi, Nicola ^a   Persico, Paola ^a   De Santis, Lucia ^a   Rabellotti, Elisa ^a   Papaleo, Enrico ^a   Ferrari, Augusto ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

IVF; Ovarian stimulation; Repeated ART cycles

Indexed keywords

CHORIONIC GONADOTROPIN; CRINONE 8; GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; AGE; ARTICLE; DRUG USE; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVULATION INDUCTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGING; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; RECOMBINANT PROTEINS;

EID: 18844384708     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400021094     Document Type: Article

References (15)

1. Maroulis GB. Effect of aging on fertility and pregnancy. Semin Reprod Endocrinol 1991;9:165-175.
2. van Noord-Zaadstra BM, Looman CWN, Alsbach H, Habbema JDF, te Velde ER, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. Br Med J 1991;302:1361-1365.
3. Alrayyes S, Fakih H, Khan I. Effect of age and cycle responsiveness in patients undergoing intracytoplasmic sperm injection. Fertil Steril 1997;68:123-127.
4. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
5. Lindheim S, Barad D, Witt B, Ditkoff E, Sauer MV. Short-term gonadotrophin suppression with oral contraceptives benefits poor responders prior to controlled ovarian stimulation. J Assist Reprod Genet 1996;13:745-747.
6. Faber B, Mayer J, Cox B, et al. Cessation of gonadotrophin-releasing hormone agonist therapy combined with high-dose gonadotrophin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998;69:826-830.
7. Surrey E, Bower J, Hill D, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administrated to poor responders who are undergoing in-vitro fertilisation. Fertil Steril 1998;69:419-424.
8. Hoveyda F, Engmann L, Steele J, Lopez Bernal A, Barlow DH. Ovarian response in three consecutive in vitro fertilization cycles. Fertil Streril 2002;77:706-710.
9. Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 1989;11:61-109.
10. Piette C, de Mouzon J, Bachelot A, Spira A. In-vitro fertilization: influence of woman's age on pregnancy rates. Hum Reprod 1990;5:56-59.
11. Scott RT, Hofmann GE Jr. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11.
12. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, Bene MC, Landes P, Faure G. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril 1991;56:928-932.
13. Platia MP, Bloomquist G, Williams RF, Hodgen GD. Refractoriness to gonadotropin therapy: how to distinguish ovarian failure versus pseudoovarian resistance caused by neutralizing antibodies. Fertil Steril 1984;42:779-784.
14. Meyer WR, Lavy G, DeCherney AH, Visintin I, Economy K, Luborsky JL. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol 1990;75:795-799.
15. Kolibianakis E, Osmanagaoglu K, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Effect of repeated assisted reproductive technology cycles on ovarian response. Fertil Steril 2002;77:967-970.